Over the past several years, the CEIRS Center directors and members of the CEIRS Pandemic Response Planning Committee (PRAC) have worked to develop the CEIRS Influenza Response Plan, in coordination with CEIRS NIAID leadership. The plan details a strategic approach for a CEIRS response to an influenza pandemic or novel influenza virus with pandemic potential… Read more »
Dr. Florian Krammer, a Professor at the Icahn School of Medicine at Mount Sinai and part of the Center for Research on Influenza Pathogenesis (CRIP), talks about efforts to develop one of the first antibody-based tests for SARS-CoV-2 infections. Some patients may exhibit few, if any, symptoms of COVID-19, proving these tests to be important to determine whether people have been infected with COVID-19.
Dr. Ben Cowling and Way Wen Lim, from The University of Hong Kong, part of SJCEIRS, co-authored an opinion piece about ongoing efforts and effective control measures for limiting the COVID-19 outbreak.
Lauren Sauer and Dr. Andrew Pekosz, researchers from Johns Hopkins University and JHCEIRS, speak as part of a panel of experts on infectious disease and public health. Their panel discussion was recorded at a U.S. House of Representatives office building in Washington, DC.
Investigators Peter Thielen and Tom Mehoke, from Johns Hopkins University Applied Physics Laboratory, part of the JHCEIRS Center, discuss their efforts toward sequencing the SARS-CoV-2 virus from clinical samples. Their use of the MinION handheld sequencers and protocol optimization advances will allow them to deploy these units at point-of-care settings to deliver same-day sequencing results.
A global team of researchers, including investigators part of the St. Jude Center of Excellence for Influenza Research and Surveillance (SJCEIRS), show in a new study that ferrets are susceptible to the SARS-CoV-2 virus, and that infected ferrets are able to transmit the virus to other ferrets through both direct and indirect contact (Kim 2020). The study, published in Cell Host & Microbe by Young-Il Kim, et al., describes an important new tool in the fight against the global COVID-19 pandemic.
Researchers around the world, including several CEIRS investigators, are urgently experimenting with various therapeutic approaches. Whether it is by repurposing existing antivirals, designing novel small molecule inhibitors, or exploiting the adaptive immune response, the common goal is clear: stop SARS-CoV-2 and its 29 proteins from overcoming humans’ cellular machinery.
The 12th Centers of Excellence for Influenza Research and Surveillance (CEIRS) Annual Network Meeting was hosted by Johns Hopkins CEIRS from June 23-26, 2019 in Baltimore, Maryland. Over the course of the meeting, researchers presented new and ongoing influenza research and surveillance efforts, and Center Principal Investigators shared updates on ongoing projects, highlighting key accomplishments… Read more »
The Arthur S. Flemming Award which recognizes exceptional scientific achievements of federal employees was awarded to CEIRS investigator, Dr. Amy Vincent in June 2019 for her work in animal health. Dr. Vincent is a Research Veterinary Medical Officer with the United States Department of Agriculture and affiliated with the CEIRS Center for Research Pathogenesis (CRIP)…. Read more »
Dr. Adolfo García-Sastre, from the Center for Research on Influenza Pathogenesis (CRIP), was elected to the National Academy of Sciences in April 2019. This prestigious appointment recognizes a career of original work and notable research accomplishments. Just a couple of Dr. García-Sastre’s outstanding contributions to the state of the science include developing a rapid system… Read more »